Mortgage Blog
Ray Trapp: I Got Next! The future after a cancer diagnosis
Since we are entering the holiday season, I liken a cancer diagnosis to the changing points in my three favorite holiday movies.
Inno Under 25: Marie Brodsky, WISE Cities
This Rockville native founded a company whose purpose is to enrich the lives of older adults.
Rating agency drops outlook for UF Health Jacksonville after margins drop
The rating downgrade comes after the hospital's operating margin tumbled.
ProKidney makes two changes to C-suite, terminating long-serving COO and promoting from within for chief business officer
Just two weeks after a sudden CEO change, ProKidney once again has made two significant changes to its C-suite. It has promoted Nikhil Pereira-Kamath to chief business officer and terminated the employment of one of its COO, one of its longest-serving executives. We've got the details.
Pennsylvania banks show Q3 stress but outpace nation for deposits: FDIC data
Mixed messages from Q3 bank data: deposits grow in Keystone State but combined bank earnings significantly lower than last year or 2021.
Inno Under 25: Phoebe Martin, Venture Capital Summit and Georgetown Student Capital Partners
She was inspired to start the Georgetown venture capital program after a visit to Miami in May 2022.
Citizens continues to close Stop & Shop branches, replaces with ITMs
In November, more bank branches closed than opened in Massachusetts, returning to a trend of widespread closures after October’s outlier month of more openings.
Pennsylvania banks show Q3 stress but largely outperform nation: FDIC data
Mixed messages from Q3 bank data: deposits grow in Keystone State but combined bank earnings significantly lower than last year or 2021.
Ally Financial’s Diane Morais to retire next year as bank continues CEO search
A high-ranking, Charlotte-based executive with Ally Financial Inc. will retire next year, with the bank disclosing the move even as its search for its next CEO continues.
United Therapeutics extends licensing deal with Eli Lilly even as generic competition intensifies
The company is still betting on some revenue from the Eli Lilly partnership even as it faces stiff competition from generic drugmakers.